CH588867A5 - - Google Patents

Info

Publication number
CH588867A5
CH588867A5 CH1618372A CH1618372A CH588867A5 CH 588867 A5 CH588867 A5 CH 588867A5 CH 1618372 A CH1618372 A CH 1618372A CH 1618372 A CH1618372 A CH 1618372A CH 588867 A5 CH588867 A5 CH 588867A5
Authority
CH
Switzerland
Application number
CH1618372A
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Publication of CH588867A5 publication Critical patent/CH588867A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1228—Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
    • C07K16/1235—Salmonella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1228—Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1228—Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
    • C07K16/1232—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH1618372A 1971-11-17 1972-11-07 CH588867A5 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2157148A DE2157148A1 (de) 1971-11-17 1971-11-17 Immunisierungsmittel, verfahren zur herstellung und seine verwendung

Publications (1)

Publication Number Publication Date
CH588867A5 true CH588867A5 (enExample) 1977-06-15

Family

ID=5825419

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1618372A CH588867A5 (enExample) 1971-11-17 1972-11-07

Country Status (10)

Country Link
JP (1) JPS5512002B2 (enExample)
AT (1) AT332539B (enExample)
BE (1) BE791489A (enExample)
CH (1) CH588867A5 (enExample)
DD (1) DD102410A5 (enExample)
DE (1) DE2157148A1 (enExample)
FR (1) FR2160542B1 (enExample)
GB (1) GB1416544A (enExample)
NL (1) NL7215221A (enExample)
SE (1) SE406419B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3516119A1 (de) * 1985-05-04 1986-11-06 Biotest Pharma GmbH, 6000 Frankfurt Polyvalentes hyperimmunglobulin-praeparat
DE10331974A1 (de) * 2003-07-14 2005-02-17 Uni-Klinikum Schleswig-Holstein Campus Kiel Verfahren zur Herstellung und Verwendung antimikrobielle Proteine induzierender Faktoren
WO2014097154A1 (en) * 2012-12-20 2014-06-26 Zakład Badawczo-Wdrożeniowy Ośrodka Salmonella "Immunolab" Sp. Z O.O. A polyvalent combined immunising and/or therapeutic preparation for use in bacterial infections or food poisoning, particularly salmonellosis, a method for production of this preparation, its use and a vaccine comprising this preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1468630A (fr) * 1963-03-14 1967-02-10 Taisho Pharmaceutical Co Ltd Préparation du lipide alpha purifié à partir de lipide alpha brut dérivé des lipopolysaccharides de bactéries à gram-négatif

Also Published As

Publication number Publication date
AU4902772A (en) 1974-05-23
JPS5512002B2 (enExample) 1980-03-29
SE406419B (sv) 1979-02-12
FR2160542A1 (enExample) 1973-06-29
GB1416544A (en) 1975-12-03
ATA975872A (de) 1976-01-15
NL7215221A (enExample) 1973-05-21
AT332539B (de) 1976-10-11
BE791489A (fr) 1973-05-16
DE2157148A1 (de) 1973-05-24
JPS4861621A (enExample) 1973-08-29
DD102410A5 (enExample) 1973-12-12
FR2160542B1 (enExample) 1976-04-23

Similar Documents

Publication Publication Date Title
FR2134421B1 (enExample)
CS178444B2 (enExample)
FR2160542B1 (enExample)
AU2941471A (enExample)
AU467721B2 (enExample)
CS153733B1 (enExample)
CS153262B1 (enExample)
CS151117B1 (enExample)
CS151671B1 (enExample)
CS154159B1 (enExample)
CS148653B1 (enExample)
CS156113B1 (enExample)
CS153579B2 (enExample)
CS156740B1 (enExample)
CS150866B1 (enExample)
CS151378B1 (enExample)
CH561640A5 (enExample)
CH601434A5 (enExample)
CH570556A5 (enExample)
CH559129A5 (enExample)
CH564255A5 (enExample)
CH561899A5 (enExample)
CH590845A5 (enExample)
CH560277B5 (enExample)
DD100576A1 (enExample)

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased